RT @drandrewsharp: So one of the questions asked by KNOCOUT PE is, would these protocols be taken up in clinical practice and could there b…
So one of the questions asked by KNOCOUT PE is, would these protocols be taken up in clinical practice and could there be a safety signal, given that 31% of patients in KNOCOUT received just 12mg or less of alteplase as their CDT protocol? https://t.co/LlD
Catheter-directed thrombolysis trials: - ULTIMA59 https://t.co/HFnU7zJJGR - SEATTLE II https://t.co/MRV4PQzOUj - PERFECT https://t.co/hYEeHcp8bV - Optalyse https://t.co/AnQY5wbcYj 7/9
@MarcVorpahl @CEngelings @DGK_org @DjawidHashemi @P_Enghard https://t.co/kWXgqGbXeR https://t.co/iOfFPx9ZdU https://t.co/8dNRGyV4i6 There are studies, our clinical experience is promising as well. https://t.co/mqRHXt0Ebc
RT @ELS_Cardiology: Read @JACCJournals Top read article in 2018. Cardiovascular Interventions: Lower doses of tPA and shorter infusion dur…
Read @JACCJournals Top read article in 2018. Cardiovascular Interventions: Lower doses of tPA and shorter infusion durations than previously studied appear to be safe and effective in acute intermediate-risk PE patients #ACC19 https://t.co/tOGulCjmPB
@spiritus_bah @MSampleMD We loop the catheters and use a lot(!) of tegaderms. No sticking the leg or neck. Pts seem to like it, minimizes bleeding and with OPTALYSE tx protocol, tx can be short (2-4 hrs). https://t.co/kO2edTyazg
RT @OrenFriedman: I believe @vic_tapson likes to call this the “how low can you go” (RE tPA) trial ! https://t.co/Ld120xAazG
I believe @vic_tapson likes to call this the “how low can you go” (RE tPA) trial !
RT @PERTConsortium: #PEjournalwatch RANDOMIZED TRIAL OF OPTIMUM DURATION OF ACOUSTIC PULSE CDT IN ACUTE IM RISK PE: OPTALYSE PE @vic_tap…
RT @PERTConsortium: #PEjournalwatch RANDOMIZED TRIAL OF OPTIMUM DURATION OF ACOUSTIC PULSE CDT IN ACUTE IM RISK PE: OPTALYSE PE @vic_tap…
RT @PERTConsortium: #PEjournalwatch RANDOMIZED TRIAL OF OPTIMUM DURATION OF ACOUSTIC PULSE CDT IN ACUTE IM RISK PE: OPTALYSE PE @vic_tap…
RT @PERTConsortium: #PEjournalwatch RANDOMIZED TRIAL OF OPTIMUM DURATION OF ACOUSTIC PULSE CDT IN ACUTE IM RISK PE: OPTALYSE PE @vic_tap…
RT @PERTConsortium: #PEjournalwatch RANDOMIZED TRIAL OF OPTIMUM DURATION OF ACOUSTIC PULSE CDT IN ACUTE IM RISK PE: OPTALYSE PE @vic_tap…
RT @PERTConsortium: #PEjournalwatch RANDOMIZED TRIAL OF OPTIMUM DURATION OF ACOUSTIC PULSE CDT IN ACUTE IM RISK PE: OPTALYSE PE @vic_tap…
RT @PERTConsortium: #PEjournalwatch RANDOMIZED TRIAL OF OPTIMUM DURATION OF ACOUSTIC PULSE CDT IN ACUTE IM RISK PE: OPTALYSE PE @vic_tap…
RT @PERTConsortium: #PEjournalwatch RANDOMIZED TRIAL OF OPTIMUM DURATION OF ACOUSTIC PULSE CDT IN ACUTE IM RISK PE: OPTALYSE PE @vic_tap…
RT @PERTConsortium: #PEjournalwatch RANDOMIZED TRIAL OF OPTIMUM DURATION OF ACOUSTIC PULSE CDT IN ACUTE IM RISK PE: OPTALYSE PE @vic_tap…
RT @PERTConsortium: #PEjournalwatch RANDOMIZED TRIAL OF OPTIMUM DURATION OF ACOUSTIC PULSE CDT IN ACUTE IM RISK PE: OPTALYSE PE @vic_tap…
RT @PERTConsortium: #PEjournalwatch RANDOMIZED TRIAL OF OPTIMUM DURATION OF ACOUSTIC PULSE CDT IN ACUTE IM RISK PE: OPTALYSE PE @vic_tap…
RT @PERTConsortium: #PEjournalwatch RANDOMIZED TRIAL OF OPTIMUM DURATION OF ACOUSTIC PULSE CDT IN ACUTE IM RISK PE: OPTALYSE PE @vic_tap…
RT @PERTConsortium: #PEjournalwatch RANDOMIZED TRIAL OF OPTIMUM DURATION OF ACOUSTIC PULSE CDT IN ACUTE IM RISK PE: OPTALYSE PE @vic_tap…
#PEjournalwatch RANDOMIZED TRIAL OF OPTIMUM DURATION OF ACOUSTIC PULSE CDT IN ACUTE IM RISK PE: OPTALYSE PE @vic_tapson @drksterling @DrMahirElder @Robert_Maholic @CharlesBRoss3 Et al https://t.co/8nQydZbuYW https://t.co/ifUExK0fuP
The OPTALYSE trial got published today. Less tPA and a for a shorter duration in intermediate and high-risk PE. #BustinClots #Thrombolysis #EKOS @BTG #PulmCCM #PulmCrit #PulmonaryEmbolism #CriticalCare #ICU https://t.co/zxtiTKXGs6
RT @drandrewsharp: OPTALYSE-PE published. Suggests we can treat PE with US-assisted catheter-directed thrombolysis using very low doses of…
RT @drandrewsharp: OPTALYSE-PE published. Suggests we can treat PE with US-assisted catheter-directed thrombolysis using very low doses of…
RT @drandrewsharp: OPTALYSE-PE published. Suggests we can treat PE with US-assisted catheter-directed thrombolysis using very low doses of…
RT @drandrewsharp: OPTALYSE-PE published. Suggests we can treat PE with US-assisted catheter-directed thrombolysis using very low doses of…
RT @drandrewsharp: OPTALYSE-PE published. Suggests we can treat PE with US-assisted catheter-directed thrombolysis using very low doses of…
OPTALYSE-PE published. Suggests we can treat PE with US-assisted catheter-directed thrombolysis using very low doses of alteplase - as low as 8mg - offloading RV within 48 hrs. Important data given frequency of older patients with PE at high bleeding risk: